肝脏立体定向体部放疗后的影像学特征
本文综述了肝脏立体定向体部放疗(SBRT)的基本原理及其治疗后肿瘤和周围肝实质的可预测影像学表现模式。SBRT后肿瘤大小和强化变化常延迟出现,周围肝实质的局灶性肝脏反应可能被误判为无应答或肿瘤复发,熟悉其模式和时间规律有助于避免误判。
要点
- SBRT后肿瘤大小和强化变化常延迟,评估应答需结合时间规律。
- 周围肝实质局灶性肝脏反应可类似肿瘤无应答或复发,需注意鉴别。
- 熟悉SBRT后影像表现模式和时间规律可避免常见陷阱。
核心结论
- SBRT后肿瘤及周围肝实质的影像学表现具有可预测的模式,熟悉其病理生理机制和时间规律有助于正确评估肿瘤应答并避免误判。
研究设计与样本
- 本文为综述,回顾了SBRT的基本原理并图示治疗后肝脏肿瘤及邻近肝实质的影像学特征,重点在于避免应答评估中的陷阱。
关键影像表现/征象
- SBRT后肿瘤和周围背景肝实质的影像学特征在治疗后即刻及随访期间呈现可预测的模式。
- 周围肝实质的放射性改变表现为局灶性肝脏反应,可能被误认为肿瘤无应答或复发。
- 肿瘤应答评估主要基于大小和强化变化,但这些变化常因放射的生理效应而延迟出现。
临床应用与阅片要点
- 阅片时应了解SBRT后肿瘤大小和强化变化常延迟,避免过早判断无应答。
- 识别周围肝实质局灶性肝脏反应的模式和时间规律,避免误判为肿瘤复发。
- 注意与基准标记放置或联合治疗相关的其他陷阱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Historically, radiation therapy was not considered in treatment of liver tumors owing to the risk of radiation-induced liver disease. However, development of highly conformed radiation treatments such as stereotactic body radiation therapy (SBRT) has increased use of radiation therapy in the liver. SBRT is indicated in treatment of primary and metastatic liver tumors with outcomes comparable to those of other local therapies, especially in treatment of hepatocellular carcinoma. After SBRT, imaging features of the tumor and surrounding background hepatic parenchyma demonstrate a predictable pattern immediately after treatment and during follow-up. The goals of SBRT are to deliver a lethal radiation dose to the targeted liver tumor and to minimize radiation dose to normal liver parenchyma and other adjacent organs. Evaluation of tumor response after SBRT centers on changes in size and enhancement; however, these changes are often delayed secondary to the underlying physiologic effects of radiation. Knowledge of the underlying pathophysiologic mechanisms of SBRT should allow better understanding of the typical imaging features in detection of tumor response and avoid misinterpretation from common pitfalls and atypical imaging findings. Imaging features of radiation-induced change in the surrounding liver parenchyma are characterized by a focal liver reaction that can potentially be mistaken for no response or recurrence of tumor. Knowledge of the pattern and chronology of this phenomenon may allay any uncertainty in assessment of tumor response. Other pitfalls related to fiducial marker placement or combination therapies are important to recognize. The authors review the basic principles of SBRT and illustrate post-SBRT imaging features of treated liver tumors and adjacent liver parenchyma with a focus on avoiding pitfalls in imaging evaluation of response. Online supplemental material is available for this article. ©RSNA, 2022.
引用
- Navin, Olson, Mendiratta-Lala, et al. Imaging Features in the Liver after Stereotactic Body Radiation Therapy. Radiographics. 2022. PMID: 36240077. doi:10.1148/rg.220084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。